News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CRI Lifetree to Share Pain Research Expertise at the American Pain Society’s Annual Scientific Meeting


5/2/2013 8:57:25 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

(Salt Lake City, May 2, 2013) — CRI Lifetree, a leader in early stage clinical research with significant expertise in pain medicine and human abuse liability testing, will be sharing its expertise at the American Pain Society’s 32nd Annual Scientific Meeting, May 8-11 in New Orleans.

Miroslav "Misha" Backonja, MD, medical director of the CRI Lifetree Center for Neuroscience Research, will be at CRI Lifetree’s booth, #524. An expert in the field, Backonja’s clinical and research interest has been in neuropathic pain in its entirety, from pathophysiology to treatment.

CRI Lifetree is at the forefront of the industry, implementing human pain models to demonstrate efficacy early in the drug development process. Its strong clinical team has conducted many successful clinical studies using these models.

“We have extensive experience with a variety of human pain models, including UVB, intra-dermal capsaicin and cold pressor test,” said Backonja. “When a battery of human pain models such as these is applied during early drug discovery, specifically in Phase I, it is possible to obtain critical information on analgesic properties, dose ranging and mechanism. Findings from pain models could inform critical decisions for a greater likelihood of success for Phase II and later development.”

In addition to its experience developing novel pain models, CRI Lifetree’s Salt Lake City Research Center is the leading human abuse liability research clinic in the United States and has conducted more human abuse liability assessments than any other research center in the country. Led by Dr. Lynn Webster, one of the premier authorities in the country on pain and human abuse liability testing, the team has experience spanning cannabinoids, opioids, antidepressants and stimulants as well as new chemical entities.

CRI Lifetree provides full-service trial support, including protocol design and consultation. It also provides 21 CFR Part 11 compliant electronic assessments with the CANTAB® HAL™ touchscreen system.

Attendees of the Annual Scientific Meeting are invited to stop by booth #524 for demonstrations of the CANTAB® system and to meet with CRI Lifetree’s experts to discuss human abuse liability and pain trials and models. To schedule a free consultation, email PAINInfo@CRILifetree.com or HALInfo@CRILifetree.com or call the Salt Lake City Research Center at 801-269-8200.

About CRI Lifetree

CRI Lifetree is a leader in specialized, multi-therapeutic early stage research providing innovative solutions, high quality and timely results to sponsors. The company has significant expertise in pain disorders, human abuse liability testing, psychiatry and neurology, cognition and pediatrics. CRI Lifetree offers a broad range of Phase I-IV services and rapid access to specific patient populations to meet the requirements of complex clinical research programs. With sites in Marlton, N.J., Philadelphia and Salt Lake City, the company conducts inpatient and outpatient clinical research in special populations and healthy volunteers. For additional information, visit www.CRILifetree.com.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES